» Articles » PMID: 39296844

Association Between Persistent Musculoskeletal Pain and Incident Sarcopenia in China: the Mediating Effect of Depressive Symptoms

Overview
Specialty Public Health
Date 2024 Sep 19
PMID 39296844
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the association between musculoskeletal pain and incident sarcopenia and further explore the mediating effect of depressive symptoms among middle-aged and older Chinese adults.

Methods: Using the data from the China Health and Retirement Longitudinal Study 2011 and 2015, we included 12,788 participants in the cross-sectional analysis and 8,322 for the longitudinal analysis. Musculoskeletal pains located in the neck, back, waist, shoulder, arm, wrist, leg, knee, and ankle were self-reported at baseline and follow-up. The diagnosis criteria of sarcopenia was based on the Asian Working Group for Sarcopenia 2019. Multivariable logistic regression models were used to evaluate the association between musculoskeletal pain, and the Karlson-Holm-Breen (KHB) method was used to explore the mediating effect of depressive symptoms.

Results: Over the 4-year follow-up, 445 participants were identified with incident sarcopenia. In the longitudinal analysis, participants with baseline musculoskeletal pain (adjusted odds ratio (OR): 1.37, 95% confidence interval (CI): 1.07-1.76), persistent musculoskeletal pain (OR:1.68, 95%CI: 1.28-2.24), and persistent waist pain (OR:1.46, 95%CI: 1.04-2.03) were significantly associated with increased the risk of incident sarcopenia. Furthermore, depressive symptoms were found to partially mediate the association between musculoskeletal pain and incident sarcopenia.

Conclusion: Persistent musculoskeletal pain, especially in waist area, was positively associated with a higher risk of sarcopenia among the middle-aged and older Chinese. Depressive symptoms played a partial mediating role in this association.

References
1.
Chen L, Woo J, Assantachai P, Auyeung T, Chou M, Iijima K . Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21(3):300-307.e2. DOI: 10.1016/j.jamda.2019.12.012. View

2.
Lin T, Huang X, Guo D, Zhao Y, Song Q, Liang R . Pain as a risk factor for incident sarcopenia in community-dwelling older adults: A 1-year prospective cohort study. J Am Geriatr Soc. 2022; 71(2):546-552. DOI: 10.1111/jgs.18118. View

3.
Ferreira G, McLachlan A, Lin C, Zadro J, Abdel-Shaheed C, OKeeffe M . Efficacy and safety of antidepressants for the treatment of back pain and osteoarthritis: systematic review and meta-analysis. BMJ. 2021; 372:m4825. PMC: 8489297. DOI: 10.1136/bmj.m4825. View

4.
Gerrits M, van Marwijk H, van Oppen P, van der Horst H, Penninx B . Longitudinal association between pain, and depression and anxiety over four years. J Psychosom Res. 2014; 78(1):64-70. DOI: 10.1016/j.jpsychores.2014.10.011. View

5.
Cruz-Jentoft A, Sayer A . Sarcopenia. Lancet. 2019; 393(10191):2636-2646. DOI: 10.1016/S0140-6736(19)31138-9. View